Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Therapix Biosciences Enters into Agreement with Dalhousie University 12
CURE Pharma Enters into Agreement with Therapix Biosciences 13
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 14
Therapix Biosciences Enters into Agreement with Assuta Medical Center 15
Therapix Biosciences Enters into Agreement with Catalent 16
CURE Pharmaceutical and Therapix Biosciences to Enter into Research Agreement with Assuta Medical Centers 17
Therapix Biosciences Plans to Form Joint Venture in China 18
Acebright To Enter Into Co-Development Agreement With NasVax 19
Licensing Agreements 20
Therapix Biosciences Enters into Licensing Agreement with Belvit Pharma 20
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 21
Therapix Biosciences to Enter into Licensing Agreement with Swiss Pharma Company 22
Therapix Biosciences Enters into Licensing Agreement with Ramot at Tel Aviv University 23
Therapix Biosciences Enters into Licensing Agreement with Dekel Pharma 24
Therapix Biosciences Enters into Licensing Agreement with Nanjing BioSciKin for Anti-CD3 25
Equity Offering 26
Therapix Biosciences Completes Underwriters Exercise of Over-Allotment of Public Offering of ADSs for USD13.8 Million 26
Therapix Biosciences Raises USD1 Million in Private Placement of Shares 28
Therapix Biosciences Raises USD0.8 Million in Private Placement of Shares 29
Therapix Biosciences Raises USD0.6 Million in Private Placement of Shares 30
Therapix Biosciences Raises USD0.1 Million in Private Placement of Shares 31
Therapix Biosciences Raises USD0.2 Million in Private Placement of Shares 32
Therapix Biosciences Raises USD1 Million in Public Offering of Shares 33
Asset Transactions 34
CURE Pharma Plans to Acquire Assets from Therapix Biosciences 34
Acquisition 35
FSD Pharma to Acquire Therapix Biosciences 35
Therapix Biosciences to Acquire Dekel Pharma 37
Therapix Biosciences Acquires 48.21% Stake in Lara Pharm 38
Acebright To Acquire 10% Stake In NasVax For US$1 Million 39
Therapix Biosciences Ltd – Key Competitors 40
Therapix Biosciences Ltd – Key Employees 41
Therapix Biosciences Ltd – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
Aug 20, 2018: Therapix Biosciences reports second quarter 2018 financial results and provides business update 43
May 31, 2018: Therapix Biosciences Reports First Quarter 2018 Financial Results and Provides Business Update 45
Nov 09, 2017: Therapix Biosciences Reports Third Quarter 2017 Financial Results and Provides Business Update 47
Aug 10, 2017: Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update 48
Corporate Communications 49
Jun 27, 2018: Therapix Biosciences Updates Regarding TASE Delisting 49
May 09, 2018: Dual-Listed Therapix to Voluntarily Delist from Tel Aviv Stock Exchange 50
Nov 02, 2017: Therapix Biosciences’ Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer 51
May 24, 2017: Therapix Biosciences Announces CEO Change 52
May 03, 2017: Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer 53
Product Approvals 54
Feb 07, 2018: Therapix Biosciences Completes Pre-IND Communication With FDA on THX-110 for Tourette Syndrome: Clinical Development to Proceed as Projected 54
Clinical Trials 55
Jun 11, 2018: Therapix Biosciences Sponsors the 2018 Annual Meeting of the European Society for the Study of Tourette Syndrome 55
Jun 05, 2018: Therapix Biosciences Announces Enrollment of the First Patient for Clinical Trial at Assuta Medical Center for Treating Obstructive Sleep Apnea Using Cannabinoid-based Drug 56
Apr 09, 2018: Therapix Biosciences Announces Topline Results of Phase IIa Study at Yale University for Tourette Syndrome Program 57
Mar 20, 2018: Therapix Biosciences Announces FDA Clearance of Investigational New Drug (IND) for Phase IIa Clinical Trial of THX-110 in the Treatment of Chronic Low Back Pain 58
Dec 04, 2017: Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program 59
Sep 27, 2017: Therapixs First-in-Class Therapy Demonstrates Reversal of Age-Related Cognitive Impairment in Pre-Clinical Study 60
May 08, 2017: Therapix Biosciences and the Hannover Medical School Enter into an Investigator-initiated Clinical Trial Agreement to Assess the Effect of TXH-TS01 in Patients with Tourette Syndrome 61
Jan 04, 2017: Therapix Biosciences Announces Enrollment of the First Patient for Clinical Trial at Yale University for Treating Tourette’s Syndrome Using Cannabinoid-based Drug 62
Other Significant Developments 63
May 15, 2018: Therapix Biosciences Issues CEO’s Letter to Shareholders 63
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Therapix Biosciences Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Therapix Biosciences Enters into Agreement with Dalhousie University 12
CURE Pharma Enters into Agreement with Therapix Biosciences 13
Therapix Biosciences Enters into Agreement with Weizmann Institute and Tel Aviv Sourasky 14
Therapix Biosciences Enters into Agreement with Assuta Medical Center 15
Therapix Biosciences Enters into Agreement with Catalent 16
CURE Pharmaceutical and Therapix Biosciences to Enter into Research Agreement with Assuta Medical Centers 17
Therapix Biosciences Plans to Form Joint Venture in China 18
Acebright To Enter Into Co-Development Agreement With NasVax 19
Therapix Biosciences Enters into Licensing Agreement with Belvit Pharma 20
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 21
Therapix Biosciences to Enter into Licensing Agreement with Swiss Pharma Company 22
Therapix Biosciences Enters into Licensing Agreement with Ramot at Tel Aviv University 23
Therapix Biosciences Enters into Licensing Agreement with Dekel Pharma 24
Therapix Biosciences Enters into Licensing Agreement with Nanjing BioSciKin for Anti-CD3 25
Therapix Biosciences Completes Underwriters Exercise of Over-Allotment of Public Offering of ADSs for USD13.8 Million 26
Therapix Biosciences Raises USD1 Million in Private Placement of Shares 28
Therapix Biosciences Raises USD0.8 Million in Private Placement of Shares 29
Therapix Biosciences Raises USD0.6 Million in Private Placement of Shares 30
Therapix Biosciences Raises USD0.1 Million in Private Placement of Shares 31
Therapix Biosciences Raises USD0.2 Million in Private Placement of Shares 32
Therapix Biosciences Raises USD1 Million in Public Offering of Shares 33
CURE Pharma Plans to Acquire Assets from Therapix Biosciences 34
FSD Pharma to Acquire Therapix Biosciences 35
Therapix Biosciences to Acquire Dekel Pharma 37
Therapix Biosciences Acquires 48.21% Stake in Lara Pharm 38
Acebright To Acquire 10% Stake In NasVax For US$1 Million 39
Therapix Biosciences Ltd, Key Competitors 40
Therapix Biosciences Ltd, Key Employees 41
Therapix Biosciences Ltd, Subsidiaries 42
List of Figures
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Therapix Biosciences Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9